Richardpruen (talk | contribs) |
Richardpruen (talk | contribs) |
||
| Line 60: | Line 60: | ||
==[https://pubmed.ncbi.nlm.nih.gov/33235307/ A randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes]== | ==[https://pubmed.ncbi.nlm.nih.gov/33235307/ A randomised controlled single-centre open-label pharmacokinetic study to examine various approaches of nicotine delivery using electronic cigarettes]== | ||
*Smokers who switch completely to e-cigarettes may reduce their relative risk of tobacco-related disease. Effective nicotine delivery from e-cigarettes is important in consumer acceptance. We assessed whether protonated nicotine and e-cigarette devices delivering greater aerosol mass increase nicotine delivery and product liking. | |||
==[https://pubmed.ncbi.nlm.nih.gov/33241632/ Commentary on Notley et al. (2020): Understanding transitions in the use of nicotine and tobacco products-the value of qualitative longitudinal research]== | ==[https://pubmed.ncbi.nlm.nih.gov/33241632/ Commentary on Notley et al. (2020): Understanding transitions in the use of nicotine and tobacco products-the value of qualitative longitudinal research]== | ||
edits